Tissue-equivalent material boluses, which are thick enough to provide an adequate dose build-up in the skin and superficial chest wall, are commonly used during post-mastectomy radiotherapy. Skin dose contributions

of boluses and the dose delivered to skin and subcutaneous tissue are important, especially in locally advanced breast cancer [6]. The American Society of Clinical Oncology published treatment guidelines for post-mastectomy radiotherapy in 2001. These guidelines stated that the chest wall should be treated adequately but they did not comment on the use of boluses [7]. To our knowledge, the mean, minimum, and maximum skin doses associated with different durations of bolus

applications have not been reported. The purpose of this prospective dosimetric study was to calculate the chest-wall www.selleckchem.com/products/DAPT-GSI-IX.html skin dose associated with various frequencies of bolus applications in post-mastectomy three-dimensional conformal radiotherapy (3D-CRT) and to provide detailed information to aid in the selection of an appropriate bolus regimen in this clinical setting. Methods CT simulation We performed CT-simulation of 22 patients immobilized with a breast-board. Each patient was positioned supine SN-38 order on the breast board with the ipsilateral arm abducted above the head; board angles were tailored according to the patient’s anatomy. Patients were scanned with a 6 detector helical CT (CT Brilliance, Philips 3-oxoacyl-(acyl-carrier-protein) reductase Medical Systems, Netherlands) with 5-mm slices from mid-neck to mid-abdomen. Volumes of interest The external surface of the patient and lung contours were defined by automated density gradient tracking then edited and verified by physicians FA and RD. The chest wall for the clinical target volume (CTV) was delineated on corresponding transverse CT images (Figure 1) by FA and RD using

the external skin surface anteriorly, the rib-soft tissue interface posteriorly, the inferior aspect of the clavicular head superiorly and 1-cm below the contralateral inframammary fold inferiorly. Medial and lateral borders of the CTV were delineated considering lateral border of the sternum and the mid-axillary line, respectively. Figure 1 Skin mTOR activator structure (green line) and clinical target volume (dark-blue line). To evaluate skin dose accurately, another volume including 2-mm surface thickness of the CTV was contoured (Figure 1) as skin structure. The planning target volume (PTV) was defined by adding 5-mm to the CTV. However, the superficial contour of the PTV was outlined 3-mm deep to the skin surface since the build-up effect would cause apparent underdosage in the dose-volume histograms (DVH) and difficulties in the evaluation of the treatment plans. 3D-CRT planning The Precise PLAN®2.11 (Elekta, Crawley, UK) treatment planning system (TPS) was used for 3D-CRT planning.